Study finds 96% Covid-19 patients have antibodies year after recovery | India News indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
When checking whether people had antibodies for coronavirus variants, the rate was 90% both six months and one year later for those who had medium to severe symptoms.
A PCR test shows whether the novel coronavirus sampled is a variant. (Provided by the Ibaraki prefectural institute for health)
About 90 percent of people fully inoculated by the Pfizer-BioNTech vaccine are well protected from variants of the novel coronavirus, having produced antibodies stimulated to better fight them off, Japanese researchers said on May 12.
The vaccine is the only one currently available in Japan.
A team of researchers at Yokohama City University reported the vaccine has a high efficacy against variants after analyzing how it protects against the original form of the virus and seven types of variants, including those believed to be highly contagious and can elude the immune system.
Around 90 percent of those who received the vaccine developed by U.S. pharmaceutical giant Pfizer Inc. were found to have antibodies against the various COVID-19 variants detected in Japan, a university study showed.
NHK - May 19
The two mass coronavirus vaccination centers set up by the Self-Defense Forces will accept reservations from people in wider areas starting Monday. They will cover residents aged 65 and older in all parts of Tokyo and Osaka.
dailymail.co.uk - May 18
A compact toilet paper that packs so much into a single roll it cold be dropped from the top of the Statue of Liberty three times before running out has been created.
NHK - May 18
Japanese marine researchers have successfully captured videos of a Pacific sleeper shark, a species whose life in deep ocean waters has yet to be fully understood.